BLASTP 2.12.0+


Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro A.
Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J.
Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs", Nucleic Acids Res. 25:3389-3402.


Reference for composition-based statistics: Alejandro A. Schaffer,
L. Aravind, Thomas L. Madden, Sergei Shavirin, John L. Spouge, Yuri
I. Wolf, Eugene V. Koonin, and Stephen F. Altschul (2001),
"Improving the accuracy of PSI-BLAST protein database searches with
composition-based statistics and other refinements", Nucleic Acids
Res. 29:2994-3005.



Database: VFDB_setB_pro.fas
           27,982 sequences; 13,298,383 total letters



Query= g1252.t1

Length=383
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  153     7e-43
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  153     1e-42
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  151     6e-42
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  150     6e-42
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  150     7e-42
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  150     8e-42
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  150     1e-41
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  150     1e-41
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  150     1e-41
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  150     2e-41
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  149     3e-41
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  147     2e-40
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  58.2    3e-09
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  48.9    2e-06
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  48.5    3e-06
VFG007027(gb|WP_001092347) (rtxD) RTX toxin transporter RtxD [MAR...  48.5    4e-06
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  48.5    4e-06
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  48.5    4e-06
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  48.5    4e-06


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 153 bits (387),  Expect = 7e-43, Method: Compositional matrix adjust.
 Identities = 127/332 (38%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A  A  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARTAVSQAQAAVKAALAEESSARAALGGDVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q E+Q A    + A   L  T++RAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 153 bits (386),  Expect = 1e-42, Method: Compositional matrix adjust.
 Identities = 129/332 (39%), Positives = 175/332 (53%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  99

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  100  -----------DVLAYERAKNELVQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRR  148

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  149  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  199

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q E+Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  200  QPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDMWVD  259

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  260  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  319

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  320  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 151 bits (381),  Expect = 6e-42, Method: Compositional matrix adjust.
 Identities = 128/332 (39%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  99

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  100  -----------DVLAYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  148

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  149  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  199

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  200  QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  259

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  260  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  319

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  320  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 150 bits (380),  Expect = 6e-42, Method: Compositional matrix adjust.
 Identities = 128/332 (39%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 150 bits (380),  Expect = 7e-42, Method: Compositional matrix adjust.
 Identities = 128/332 (39%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 150 bits (380),  Expect = 8e-42, Method: Compositional matrix adjust.
 Identities = 128/336 (38%), Positives = 174/336 (52%), Gaps = 33/336 (10%)

Query  41   LLAWWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDF  100
               WW    +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  + 
Sbjct  45   FFLWW----QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-  99

Query  101  RQRLRAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAET  158
                             L  +RAK E +   RQ   Q    S+A A     RA+  RA+ 
Sbjct  100  ---------------DVLAYERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQD  144

Query  159  DWRRYRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAA  218
            D RR   LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R      
Sbjct  145  DLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE-----  199

Query  219  LAQRQAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQ  278
                Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL  
Sbjct  200  ----QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSD  255

Query  279  AYVVANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGN  336
             +V AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN
Sbjct  256  VWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGN  315

Query  337  FTKIVQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            + K+VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  316  WIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 150 bits (379),  Expect = 1e-41, Method: Compositional matrix adjust.
 Identities = 128/336 (38%), Positives = 174/336 (52%), Gaps = 33/336 (10%)

Query  41   LLAWWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDF  100
               WW    +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  + 
Sbjct  39   FFLWW----QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-  93

Query  101  RQRLRAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAET  158
                             L  +RAK E +   RQ   Q    S+A A     RA+  RA+ 
Sbjct  94   ---------------DVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQD  138

Query  159  DWRRYRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAA  218
            D RR   LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R      
Sbjct  139  DLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE-----  193

Query  219  LAQRQAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQ  278
                Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL  
Sbjct  194  ----QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSD  249

Query  279  AYVVANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGN  336
             +V AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN
Sbjct  250  VWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGN  309

Query  337  FTKIVQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            + K+VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  310  WIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 150 bits (379),  Expect = 1e-41, Method: Compositional matrix adjust.
 Identities = 128/332 (39%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 150 bits (378),  Expect = 1e-41, Method: Compositional matrix adjust.
 Identities = 128/332 (39%), Positives = 174/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 150 bits (378),  Expect = 2e-41, Method: Compositional matrix adjust.
 Identities = 127/336 (38%), Positives = 176/336 (52%), Gaps = 33/336 (10%)

Query  41   LLAWWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDF  100
               WW    +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  + 
Sbjct  45   FFLWW----QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-  99

Query  101  RQRLRAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAET  158
                             L  +RAK E +   RQ  +Q    S+A A     RA+  RA+ 
Sbjct  100  ---------------DVLAYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQD  144

Query  159  DWRRYRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAA  218
            D RR   LA+  A S + L +A AA  +A+AA + A AEE   RAA           + A
Sbjct  145  DLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALG--------GQVA  196

Query  219  LAQRQAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQ  278
            L + Q  +Q A    + A   L  T+IRAP  G+V +R V++ Q V  G PL+AVVPL  
Sbjct  197  L-REQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSD  255

Query  279  AYVVANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGN  336
             +V AN+KETQL  ++ GQP EL  D +G++  +RG V   +  +G+ F+L+P  NATGN
Sbjct  256  VWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGMVAGFSAGTGSAFSLIPAQNATGN  315

Query  337  FTKIVQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            + K+VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  316  WIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 149 bits (376),  Expect = 3e-41, Method: Compositional matrix adjust.
 Identities = 127/332 (38%), Positives = 173/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  93

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  94   -----------DVLAYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  142

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  143  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  193

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IR P  G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  194  QPAVQTAIGRLKDAWLNLQRTQIRTPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  253

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  254  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  313

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  314  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 147 bits (371),  Expect = 2e-40, Method: Compositional matrix adjust.
 Identities = 127/332 (38%), Positives = 173/332 (52%), Gaps = 32/332 (10%)

Query  45   WWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQRL  104
            WW   +  E T+DAYV    V V+ Q  G V +VL  D   V+ GD+L  LD  +     
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDN-----  99

Query  105  RAAEAREAAAQAALEAQRAKLETLD--RQLLEQAQTISRARADGEAARAEWRRAETDWRR  162
                         L  +RAK E +   RQ   Q    S+A A     RA+  RA+ D RR
Sbjct  100  -----------DVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRR  148

Query  163  YRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQR  222
               LA+  A S + L +A AA  +A+AA + A AEE   RAA     S R          
Sbjct  149  RSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE---------  199

Query  223  QAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPGLPLLAVVPLEQAYVV  282
            Q  +Q A    + A   L  T+IRA   G+V +R V++ Q V  G PL+AVVPL   +V 
Sbjct  200  QPAVQTAIGRLKDAWLNLQRTQIRASADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVD  259

Query  283  ANYKETQLERIRPGQPVELEVDTFGRR--WRGRVDSVAPASGAVFALLPPDNATGNFTKI  340
            AN+KETQL  ++ GQP EL  D +G++  +RGRV   +  +G+ F+L+P  NATGN+ K+
Sbjct  260  ANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKV  319

Query  341  VQRFPVRIRLDADAAERGRLLPGMSVIATVDT  372
            VQR PVRI L+ +  +R  L  G+S+   VDT
Sbjct  320  VQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 58.2 bits (139),  Expect = 3e-09, Method: Compositional matrix adjust.
 Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 43/289 (15%)

Query  30   GGLAGAIALAALL-AWWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQA  88
             G    I L   L    +        T++A+V A+   V+A V GY+  + V ++ +V+ 
Sbjct  7    AGFPVIILLCVFLFILIYHYSYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKK  66

Query  89   GDLLLRLD--PRDFRQRLRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADG  146
            G  L  +   P +   R   +  +EA AQ  L          ++Q       + + +   
Sbjct  67   GQPLFTVFKAPYELAYRKAVSHVQEAKAQLLL---------FNKQ-------VEKTKYLL  110

Query  147  EAARAEWRRAETDWRRYRQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKD  206
            +A +  + +   D+      + +HA S+                    +     + AA  
Sbjct  111  QAQKELYEKFRFDYEHNYSASRDHAVSK-----------------LTVNTMLKEKNAALS  153

Query  207  VLKSRRREAEAALAQ---RQAELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQY  263
             LK+  +E E    Q   ++ ++    A  + A+  LD+T + A   G V    V L   
Sbjct  154  KLKALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVALGTP  213

Query  264  VTPGLPLLAVVPLEQAYVVANYKETQLERIRPGQPVELEVDTFGRRWRG  312
            +    P+ A+   +  ++ AN+ ET L R++PG     +V  F R + G
Sbjct  214  IKTRKPVFAIADTDTLFIQANFNETDLRRVQPGD----KVSIFPRMYFG  258


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 48.9 bits (115),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 62/224 (28%), Positives = 85/224 (38%), Gaps = 78/224 (35%)

Query  44   WWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQR  103
            W   SGR LE  D   +R        QVSG +  V   D + V+ GDLL  +DPR F   
Sbjct  59   WQEYSGR-LEAIDQVDIRP-------QVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  104  LRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADGEAARAEWRRAETDWRRY  163
            L  A+A+ A+A+A              Q+   A  +S                     R 
Sbjct  111  LNRAKAQLASAEA--------------QVTYTASNLS---------------------RI  135

Query  164  RQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQRQ  223
            ++L   +A SRQ L   D A   AR+A                                 
Sbjct  136  QRLIQSNAVSRQEL---DLAENDARSA--------------------------------N  160

Query  224  AELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPG  267
            A LQ A AA + AR  L+ T I AP +GR+ + +V +   V+ G
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAG  204


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 48.5 bits (114),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 62/224 (28%), Positives = 85/224 (38%), Gaps = 78/224 (35%)

Query  44   WWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQR  103
            W   SGR LE  D   +R        QVSG +  V   D + V+ GDLL  +DPR F   
Sbjct  59   WQEYSGR-LEAIDQVDIRP-------QVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  104  LRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADGEAARAEWRRAETDWRRY  163
            L  A+A+ A+A+A              Q+   A  +S                     R 
Sbjct  111  LNRAKAQLASAEA--------------QVTYTASNLS---------------------RI  135

Query  164  RQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQRQ  223
            ++L   +A SRQ L   D A   AR+A                                 
Sbjct  136  QRLIQSNAVSRQEL---DLAENDARSA--------------------------------N  160

Query  224  AELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPG  267
            A LQ A AA + AR  L+ T I AP +GR+ + +V +   V+ G
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAG  204


>VFG007027(gb|WP_001092347) (rtxD) RTX toxin transporter RtxD 
[MARTX (VF0265) - Exotoxin (VFC0235)] [Vibrio cholerae O1 biovar 
El Tor str. N16961]
Length=453

 Score = 48.5 bits (114),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 38/198 (19%)

Query  200  RQRAAKDVLKSRRREAEAALA-------------QRQAELQEAAAARELA----RHALDD  242
            +QRA  +VLKS+    E  L              +RQA LQ A+  +EL+    R  L+ 
Sbjct  245  QQRAELEVLKSQYESLEERLTGFKAQKQREWLEKRRQARLQLASLNQELSKVREREQLEI  304

Query  243  TEIRAPFAGRVGQRKV-RLRQYVTPGLPLLAVVP---LEQAYVVANYKETQLERIRPGQP  298
              IR+P  G V Q  V  L   + P   L+ +VP   ++QA V    K+     + PGQ 
Sbjct  305  --IRSPVDGTVQQLSVYTLGAVLQPAQNLMIIVPENRVQQAEVQILNKDVGF--VYPGQS  360

Query  299  VELEVDTFGRRWRGRVDSVAPASGAVFALLPPDNATGNFTKIVQRFPVRIRLDADA----  354
            V ++VD F     G +D       A    +  D+ T     +V  FP +I+L  +     
Sbjct  361  VTVKVDAFPYTRYGTID-------AELLSISRDSTTDEQLGLV--FPAQIQLKTNHIMID  411

Query  355  AERGRLLPGMSVIATVDT  372
             +   L PGMSV+A + T
Sbjct  412  GQTVELTPGMSVVAEIKT  429


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 48.5 bits (114),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 62/224 (28%), Positives = 85/224 (38%), Gaps = 78/224 (35%)

Query  44   WWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQR  103
            W   SGR LE  D   +R        QVSG +  V   D + V+ GDLL  +DPR F   
Sbjct  59   WQEYSGR-LEAIDQVDIRP-------QVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  104  LRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADGEAARAEWRRAETDWRRY  163
            L  A+A+ A+A+A              Q+   A  +S                     R 
Sbjct  111  LNRAKAQLASAEA--------------QVTYTASNLS---------------------RI  135

Query  164  RQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQRQ  223
            ++L   +A SRQ L   D A   AR+A                                 
Sbjct  136  QRLIQSNAVSRQEL---DLAENDARSA--------------------------------N  160

Query  224  AELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPG  267
            A LQ A AA + AR  L+ T I AP +GR+ + +V +   V+ G
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAG  204


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 48.5 bits (114),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 62/224 (28%), Positives = 85/224 (38%), Gaps = 78/224 (35%)

Query  44   WWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQR  103
            W   SGR LE  D   +R        QVSG +  V   D + V+ GDLL  +DPR F   
Sbjct  35   WQEYSGR-LEAIDQVDIRP-------QVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  86

Query  104  LRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADGEAARAEWRRAETDWRRY  163
            L  A+A+ A+A+A              Q+   A  +S                     R 
Sbjct  87   LNRAKAQLASAEA--------------QVTYTASNLS---------------------RI  111

Query  164  RQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQRQ  223
            ++L   +A SRQ L   D A   AR+A                                 
Sbjct  112  QRLIQSNAVSRQEL---DLAENDARSA--------------------------------N  136

Query  224  AELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPG  267
            A LQ A AA + AR  L+ T I AP +GR+ + +V +   V+ G
Sbjct  137  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAG  180


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 48.5 bits (114),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 62/224 (28%), Positives = 85/224 (38%), Gaps = 78/224 (35%)

Query  44   WWWSSGRFLEGTDDAYVRADWVAVSAQVSGYVAEVLVADDADVQAGDLLLRLDPRDFRQR  103
            W   SGR LE  D   +R        QVSG +  V   D + V+ GDLL  +DPR F   
Sbjct  59   WQEYSGR-LEAIDQVDIRP-------QVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  104  LRAAEAREAAAQAALEAQRAKLETLDRQLLEQAQTISRARADGEAARAEWRRAETDWRRY  163
            L  A+A+ A+A+A              Q+   A  +S                     R 
Sbjct  111  LNRAKAQLASAEA--------------QVTYTASNLS---------------------RI  135

Query  164  RQLADEHATSRQRLENADAAHQRARAAARRASAEEGRQRAAKDVLKSRRREAEAALAQRQ  223
            ++L   +A SRQ L   D A   AR+A                                 
Sbjct  136  QRLIQSNAVSRQEL---DLAENDARSA--------------------------------N  160

Query  224  AELQEAAAARELARHALDDTEIRAPFAGRVGQRKVRLRQYVTPG  267
            A LQ A AA + AR  L+ T I AP +GR+ + +V +   V+ G
Sbjct  161  ANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAG  204



Lambda      K        H        a         alpha
   0.318    0.130    0.373    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2934825539


Query= g2894.t1

Length=354
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  151     3e-42
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  149     1e-41
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  148     2e-41
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  148     3e-41
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  148     3e-41
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  148     3e-41
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  148     4e-41
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  148     4e-41
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  148     4e-41
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  146     1e-40
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  145     3e-40
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  145     6e-40
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  62.4    9e-11
VFG007027(gb|WP_001092347) (rtxD) RTX toxin transporter RtxD [MAR...  48.9    3e-06


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 151 bits (381),  Expect = 3e-42, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 166/316 (53%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  AQQAQSRID----TASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
               A++ +        A LAE  +A  A    VS+ E      + ++Q    R   A L+
Sbjct  157  LAHARTAVSQAQAAVKAALAEESSARAALGGDVSLRE------QPEVQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LRRTQVRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 149 bits (377),  Expect = 1e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 163/316 (52%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  53   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  102

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  103  AYERAKNELVQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E      + ++Q    R   A L+
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLRE------QPEVQTAIGRLKDAWLN  216

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  217  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPA  276

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  277  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  336

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  337  HPLRIGLSMTVKVDTS  352


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 148 bits (374),  Expect = 2e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 148 bits (374),  Expect = 3e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 160/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V  VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 148 bits (374),  Expect = 3e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 148 bits (374),  Expect = 3e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 148 bits (373),  Expect = 4e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  53   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  102

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  103  AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  216

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  217  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  276

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  277  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  336

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  337  HPLRIGLSMTVKVDTS  352


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 148 bits (373),  Expect = 4e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 148 bits (373),  Expect = 4e-41, Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 161/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  53   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  102

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  103  AYERAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  216

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  217  LQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  276

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  277  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  336

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  337  HPLRIGLSMTVKVDTS  352


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 146 bits (369),  Expect = 1e-40, Method: Compositional matrix adjust.
 Identities = 114/316 (36%), Positives = 160/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  47   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  96

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  97   AYERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  156

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  157  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  210

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++R P DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  211  LQRTQIRTPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  270

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  271  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  330

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  331  HPLRIGLSMTVKVDTS  346


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 145 bits (367),  Expect = 3e-40, Method: Compositional matrix adjust.
 Identities = 115/327 (35%), Positives = 166/327 (51%), Gaps = 40/327 (12%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  53   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  102

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    ++Q A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  103  AYERAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  153  ------------AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQA  200
                        A    +  + +SAR A G     A R+Q +V  A +G           
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQV--ALREQPAVQTA-IG-----------  208

Query  201  RRDQARLDLSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLT  260
            R   A L+L   ++RAP DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL 
Sbjct  209  RLKDAWLNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLR  268

Query  261  HVSPGQAVEIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIV  319
            H+  GQ  E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IV
Sbjct  269  HMKIGQPAELVSDLYGKQIVYRGMVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIV  328

Query  320  LEPRQAMAGKLRVGMSVEARIDTATGT  346
            L         LR+G+S+  ++DT+  +
Sbjct  329  LNREDVDRHPLRIGLSMTVKVDTSAAS  355


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 145 bits (365),  Expect = 6e-40, Method: Compositional matrix adjust.
 Identities = 114/316 (36%), Positives = 160/316 (51%), Gaps = 24/316 (8%)

Query  36   QSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLLARLDDRDFRTALAAAEADVL  95
            + T+DAYV      V P+  G V+ VL +D   VK G +LA LDD          + DVL
Sbjct  53   EETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDD----------DNDVL  102

Query  96   G---AEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHEQSRYQTLASKGAGSLQN  152
                A+  L  A    +RQ A   QA A+V   +A+L  A+ +  R   LA  GA S + 
Sbjct  103  AYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEE  162

Query  153  ----AQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQRMQARRDQARLD  208
                            A LAE  +A  A   QVS+ E         +Q    R   A L+
Sbjct  163  LAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPA------VQTAIGRLKDAWLN  216

Query  209  LSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVGNFQETQLTHVSPGQAV  268
            L   ++RA  DGQV +R ++VG  V  G+ L+AVVPL   +V  NF+ETQL H+  GQ  
Sbjct  217  LQRTQIRASADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPA  276

Query  269  EIRVDTFPGEVL-RGHVDSIAPATGLSFAPIAPDNATGNFTKVVQRIPVKIVLEPRQAMA  327
            E+  D +  +++ RG V   +  TG +F+ I   NATGN+ KVVQR+PV+IVL       
Sbjct  277  ELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDR  336

Query  328  GKLRVGMSVEARIDTA  343
              LR+G+S+  ++DT+
Sbjct  337  HPLRIGLSMTVKVDTS  352


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 62.4 bits (150),  Expect = 9e-11, Method: Compositional matrix adjust.
 Identities = 79/340 (23%), Positives = 143/340 (42%), Gaps = 36/340 (11%)

Query  16   LLVLTLLVYLLFHLLAPRVVQSTDDAYVHADFTLVAPKVAGFVQDVLVEDNQPVKAGQLL  75
            +L+   L  L++H     +   T++A+V A+   VA  V G++ ++ V++ Q VK GQ L
Sbjct  13   ILLCVFLFILIYHY--SYLFPFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKKGQPL  70

Query  76   ARLDDRDFRTALAAAEADVLGAEANLANAEANLQRQQALIEQARAKVRAEQAELVFARHE  135
              +    +  A   A + V  A+A L      +++ + L++         Q EL    +E
Sbjct  71   FTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQ--------AQKEL----YE  118

Query  136  QSRYQTLASKGAGSLQNAQQAQSRIDTASARLAEGQAAVD---ATRKQVSVLEARVGQAR  192
            + R+    +  A        A S++ T +  L E  AA+    A  K++ V + +V   +
Sbjct  119  KFRFDYEHNYSASR----DHAVSKL-TVNTMLKEKNAALSKLKALEKELEVNQQQVIVQK  173

Query  193  GDLQRMQARRDQARLDLSYCELRAPFDGQVGRRQLRVGAYVTPGSALLAVVPLQQAYVVG  252
              +  + A    A++DL    + A  +G V    + +G  +     + A+      ++  
Sbjct  174  KKIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQA  233

Query  253  NFQETQLTHVSPGQAVEIRVDTFPG-EVLRGHVDS---------IAPATGLSFAPIAPDN  302
            NF ET L  V PG  V I    + G ++  G + S            AT +        N
Sbjct  234  NFNETDLRRVQPGDKVSIFPRMYFGSKIYHGVILSRNWAASRLETHRATQIQIV----RN  289

Query  303  ATGNFTKVVQRIPVKIVLEPRQAMAGKLRVGMSVEARIDT  342
            +  N+  + QR+PV+I +     +   L +G S    I T
Sbjct  290  SESNWFLLPQRLPVQIQITDYDPVHYPLSIGASAYVYIHT  329


>VFG007027(gb|WP_001092347) (rtxD) RTX toxin transporter RtxD 
[MARTX (VF0265) - Exotoxin (VFC0235)] [Vibrio cholerae O1 biovar 
El Tor str. N16961]
Length=453

 Score = 48.9 bits (115),  Expect = 3e-06, Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 40/223 (18%)

Query  145  KGAGSLQNAQQAQSRIDTASARLAEGQAAVDATRKQVSVLEARVGQARGDLQR-MQARRD  203
            K  G ++  +Q +  ++ A  ++A+ +A ++  + Q   LE R+   +   QR    +R 
Sbjct  222  KVIGHVEYLEQEKELLE-AQRQVAQQRAELEVLKSQYESLEERLTGFKAQKQREWLEKRR  280

Query  204  QARLDLSYCE--------------LRAPFDGQVGRRQLRV---GAYVTPGSALLAVVP--  244
            QARL L+                 +R+P DG V  +QL V   GA + P   L+ +VP  
Sbjct  281  QARLQLASLNQELSKVREREQLEIIRSPVDGTV--QQLSVYTLGAVLQPAQNLMIIVPEN  338

Query  245  -LQQAYVVGNFQETQLTHVSPGQAVEIRVDTFPGEVLRGHVDSIAPATGLSFAPIAPDNA  303
             +QQA V        +  V PGQ+V ++VD FP     G +D+           I+ D+ 
Sbjct  339  RVQQAEV--QILNKDVGFVYPGQSVTVKVDAFPY-TRYGTIDA-------ELLSISRDST  388

Query  304  TGNFTKVVQRIPVKIVLEPRQAMAG----KLRVGMSVEARIDT  342
            T     +V   P +I L+    M      +L  GMSV A I T
Sbjct  389  TDEQLGLV--FPAQIQLKTNHIMIDGQTVELTPGMSVVAEIKT  429



Lambda      K        H        a         alpha
   0.319    0.131    0.354    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2649466853


Query= g3197.t1

Length=344
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  171     9e-50
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  170     1e-49
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  169     5e-49
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  168     5e-49
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  168     7e-49
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  166     3e-48
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  166     3e-48
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  166     4e-48
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  166     5e-48
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  166     5e-48
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  166     5e-48
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  163     8e-47
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  70.9    1e-13
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  50.8    6e-07
VFG007030(gb|WP_017818215) (rtxD) RTX toxin transporter RtxD [MAR...  50.8    6e-07
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  50.4    7e-07
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  50.4    8e-07
VFG007029(gb|WP_043921137) (rtxD) RTX toxin transporter RtxD [MAR...  50.4    8e-07
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  49.7    1e-06


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 171 bits (432),  Expect = 9e-50, Method: Compositional matrix adjust.
 Identities = 122/320 (38%), Positives = 176/320 (55%), Gaps = 16/320 (5%)

Query  23   FFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADF  82
            FFL WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D + 
Sbjct  45   FFL-WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDND  100

Query  83   KLAVERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALR  142
             LA ERA+        EL QA  +  +Q +  + +AA V   +A L RAQ DL R  AL 
Sbjct  101  VLAYERAKN-------ELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALA  153

Query  143  KPGYVSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTEL  201
            + G VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L
Sbjct  154  ESGAVSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRL  210

Query  202  AQAEINLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRM  261
              A +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M
Sbjct  211  KDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHM  270

Query  262  RDGQKARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFE  320
            + GQ A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV  
Sbjct  271  KIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLN  330

Query  321  ADNPLHGRIRPGMSVEAEVE  340
             ++     +R G+S+  +V+
Sbjct  331  REDVDRHPLRIGLSMTVKVD  350


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 170 bits (430),  Expect = 1e-49, Method: Compositional matrix adjust.
 Identities = 121/320 (38%), Positives = 175/320 (55%), Gaps = 16/320 (5%)

Query  23   FFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADF  82
            FFL WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D + 
Sbjct  39   FFL-WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDND  94

Query  83   KLAVERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALR  142
             LA ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL 
Sbjct  95   VLAYERAKN-------ELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALA  147

Query  143  KPGYVSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTEL  201
            + G VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L
Sbjct  148  ESGAVSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRL  204

Query  202  AQAEINLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRM  261
              A +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M
Sbjct  205  KDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHM  264

Query  262  RDGQKARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFE  320
            + GQ A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV  
Sbjct  265  KIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLN  324

Query  321  ADNPLHGRIRPGMSVEAEVE  340
             ++     +R G+S+  +V+
Sbjct  325  REDVDRHPLRIGLSMTVKVD  344


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 169 bits (427),  Expect = 5e-49, Method: Compositional matrix adjust.
 Identities = 121/320 (38%), Positives = 174/320 (54%), Gaps = 16/320 (5%)

Query  23   FFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADF  82
            FFL WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D + 
Sbjct  45   FFL-WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDND  100

Query  83   KLAVERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALR  142
             LA ERA+        EL QA  +  QQ +  + + A V   +A L RAQ DL R  AL 
Sbjct  101  VLAYERAKN-------ELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALA  153

Query  143  KPGYVSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTEL  201
            + G VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L
Sbjct  154  ESGAVSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVALREQPAVQTAIGRL  210

Query  202  AQAEINLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRM  261
              A +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M
Sbjct  211  KDAWLNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHM  270

Query  262  RDGQKARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFE  320
            + GQ A L  D +    +  G +    A +G+ FSL+P  NATGN+ KVVQR+PV+IV  
Sbjct  271  KIGQPAELVSDLYGKQIVYRGMVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLN  330

Query  321  ADNPLHGRIRPGMSVEAEVE  340
             ++     +R G+S+  +V+
Sbjct  331  REDVDRHPLRIGLSMTVKVD  350


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 168 bits (426),  Expect = 5e-49, Method: Compositional matrix adjust.
 Identities = 119/316 (38%), Positives = 174/316 (55%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + +AA V   +A L RAQ DL R  AL + G 
Sbjct  105  ERAKN-------ELVQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGA  157

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R + ++ +A   L  A 
Sbjct  158  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPEVQTAIGRLKDAW  214

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  215  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQ  274

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  275  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  334

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  335  DRHPLRIGLSMTVKVD  350


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 168 bits (425),  Expect = 7e-49, Method: Compositional matrix adjust.
 Identities = 119/317 (38%), Positives = 171/317 (54%), Gaps = 17/317 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQ-RDTLGAEIK-RLEAQIASARTELAQA  204
            VS E +    A    A SQ   A     A+    R  LG ++  R + ++ +A   L  A
Sbjct  152  VSAEEL----AHARTAVSQAQAAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDA  207

Query  205  EINLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDG  264
             +NL RT + +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ G
Sbjct  208  WLNLRRTQVRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIG  267

Query  265  QKARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADN  323
            Q A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++
Sbjct  268  QPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNRED  327

Query  324  PLHGRIRPGMSVEAEVE  340
                 +R G+S+  +V+
Sbjct  328  VDRHPLRIGLSMTVKVD  344


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 166 bits (421),  Expect = 3e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  152  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  208

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  209  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  328

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  329  DRHPLRIGLSMTVKVD  344


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 166 bits (420),  Expect = 3e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  152  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  208

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  209  LNLQRTQIRTPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  328

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  329  DRHPLRIGLSMTVKVD  344


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 166 bits (420),  Expect = 4e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  152  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  208

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  209  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  328

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  329  DRHPLRIGLSMTVKVD  344


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 166 bits (419),  Expect = 5e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  152  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  208

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  209  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  328

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  329  DRHPLRIGLSMTVKVD  344


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 166 bits (419),  Expect = 5e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  99   ERAKN-------ELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  151

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  152  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  208

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  209  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  268

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  269  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  328

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  329  DRHPLRIGLSMTVKVD  344


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 166 bits (420),  Expect = 5e-48, Method: Compositional matrix adjust.
 Identities = 118/316 (37%), Positives = 172/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  105  ERAKN-------ELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  157

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  158  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  214

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +P  G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  215  LNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  274

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  275  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  334

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  335  DRHPLRIGLSMTVKVD  350


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 163 bits (412),  Expect = 8e-47, Method: Compositional matrix adjust.
 Identities = 117/316 (37%), Positives = 171/316 (54%), Gaps = 15/316 (5%)

Query  27   WWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAV  86
            WW   +H E T++AYV G + +V  Q G  V +VL  D   V KG +L  L+D +  LA 
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  87   ERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGRAQIDLNRAEALRKPGY  146
            ERA+        EL QA  +  +Q +  + + A V   +A L RAQ DL R  AL + G 
Sbjct  105  ERAKN-------ELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGA  157

Query  147  VSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIK-RLEAQIASARTELAQAE  205
            VS E +    A    A++ +  A A+  + R     LG ++  R +  + +A   L  A 
Sbjct  158  VSAEELAHARAAVSQAQAAVKAALAEESSARA---ALGGQVSLREQPAVQTAIGRLKDAW  214

Query  206  INLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQANFKETQVGRMRDGQ  265
            +NL RT I +   G V +RS + GQ V  G  L+++VP  D+WV ANFKETQ+  M+ GQ
Sbjct  215  LNLQRTQIRASADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQ  274

Query  266  KARLTFDAFPDTPI-DGRIDSLFAASGAQFSLLPPDNATGNFTKVVQRIPVKIVFEADNP  324
             A L  D +    +  GR+    A +G+ FSL+P  NATGN+ KVVQR+PV+IV   ++ 
Sbjct  275  PAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDV  334

Query  325  LHGRIRPGMSVEAEVE  340
                +R G+S+  +V+
Sbjct  335  DRHPLRIGLSMTVKVD  350


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 70.9 bits (172),  Expect = 1e-13, Method: Compositional matrix adjust.
 Identities = 73/336 (22%), Positives = 150/336 (45%), Gaps = 37/336 (11%)

Query  11   VFLVAVGLIALAFFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQHVDK  70
            + L+ V L  L +   + F       T+NA+V   +  VA+ +   +  + V++ Q V K
Sbjct  12   IILLCVFLFILIYHYSYLF-----PFTNNAFVVANVRPVAANVKGYITNIYVKNEQEVKK  66

Query  71   GQLLVRLEDADFKLAVERAQAALATREAELAQARSKLVQQGSLIAASAADVNASQATLGR  130
            GQ L  +  A ++LA  +A        + + +A+++L+     +  +   + A +    +
Sbjct  67   GQPLFTVFKAPYELAYRKA-------VSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYEK  119

Query  131  AQIDLNRAEALRKPGYVSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRL  190
             + D     +  +   VS+  V T+  + + A S+L     +LE   V +  +  + K++
Sbjct  120  FRFDYEHNYSASRDHAVSKLTVNTMLKEKNAALSKLKALEKELE---VNQQQVIVQKKKI  176

Query  191  EAQIASARTELAQAEINLSRTLIHSPISGLVGQRSARNGQYVQVGTHLLSLVPDEDIWVQ  250
            ++ IA  +     A+I+L  T +++  +G V       G  ++    + ++   + +++Q
Sbjct  177  DSLIAVMKN----AKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQ  232

Query  251  ANFKETQVGRMRDGQKARLTFDAFPDTPIDGRI------DSLFAAS------GAQFSLLP  298
            ANF ET + R++ G K  +    FP      +I         +AAS        Q  ++ 
Sbjct  233  ANFNETDLRRVQPGDKVSI----FPRMYFGSKIYHGVILSRNWAASRLETHRATQIQIV-  287

Query  299  PDNATGNFTKVVQRIPVKIVFEADNPLHGRIRPGMS  334
              N+  N+  + QR+PV+I     +P+H  +  G S
Sbjct  288  -RNSESNWFLLPQRLPVQIQITDYDPVHYPLSIGAS  322


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 50.8 bits (120),  Expect = 6e-07, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG007030(gb|WP_017818215) (rtxD) RTX toxin transporter RtxD 
[MARTX (VF0265) - Exotoxin (VFC0235)] [Vibrio vulnificus YJ016]
Length=453

 Score = 50.8 bits (120),  Expect = 6e-07, Method: Compositional matrix adjust.
 Identities = 96/411 (23%), Positives = 159/411 (39%), Gaps = 93/411 (23%)

Query  8    RLTVFLVAVGLIALAFFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQH  67
            RLT   +++G++A   + +W  +     +T    V G    + S   +RV  + VRD Q 
Sbjct  41   RLTAITLSIGVLAALLWAYWGKLDVQATATGRLVVSGRSQVIQSYEQSRVMSIHVRDGQR  100

Query  68   VDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKL---------------VQQGS  112
            V+KG  L+ L+       + R       +  EL + R+ L                +Q +
Sbjct  101  VEKGAPLLTLDTLGVNQDITRLITQSEFQTNELIRYRTLLNDQPLVQDPMFTALPTEQQA  160

Query  113  LI-----------------------------AASAADVNA--------SQATLGRAQIDL  135
            LI                             AA  +D+NA        SQ    R    L
Sbjct  161  LINENYLSEKREFDATLASISAEMKVNRTSQAARQSDINALIQLTENISQRLAARK--TL  218

Query  136  NRAEALRKPGYVSEERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEI--------  187
            N+ + +    Y+ +E+         V R Q+A+ RA+L+  + Q  +L            
Sbjct  219  NQVKVIGHVEYLEQEKELL-----EVQR-QVAQQRAELQVLKSQYQSLEERQTGFKAQKH  272

Query  188  -----KRLEA--QIASARTELAQAEINLSRTLIHSPISGLVGQRSARN-GQYVQVGTHLL  239
                 KR +A  Q+A+   EL++        +I SP+ G V Q S    G  +Q   +L+
Sbjct  273  REWLEKRRQAKLQLAALNQELSKVREREQLEIIRSPVDGTVQQLSVYTLGAVLQPAQNLM  332

Query  240  SLVPDEDIWV-QANFKETQVGRMRDGQKARLTFDAFPDT---PIDGRIDSLF--AASGAQ  293
             +VP+  + + +       VG +  GQ   +  DAFP T    ID  + S+   + +  Q
Sbjct  333  IIVPENSVQLAEVQILNKDVGFVYPGQSVTVKVDAFPYTRYGTIDAELLSISRDSTTDEQ  392

Query  294  FSLLPPDNATGNFTKVVQRIPVKIVFEADNPLHGRIRPGMSVEAEVELRDR  344
              L+ P     N   +V  I  ++V          + PGMSV AE++   R
Sbjct  393  LGLVFPAQVQLNKNNIV--IDGQMV---------ELTPGMSVVAEIKTDKR  432


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 50.4 bits (119),  Expect = 7e-07, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 50.4 bits (119),  Expect = 8e-07, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG007029(gb|WP_043921137) (rtxD) RTX toxin transporter RtxD 
[MARTX (VF0265) - Exotoxin (VFC0235)] [Vibrio vulnificus CMCP6]
Length=453

 Score = 50.4 bits (119),  Expect = 8e-07, Method: Compositional matrix adjust.
 Identities = 97/409 (24%), Positives = 160/409 (39%), Gaps = 89/409 (22%)

Query  8    RLTVFLVAVGLIALAFFLHWWFIGRHVESTDNAYVQGEITRVASQLGARVEEVLVRDNQH  67
            RLT   +++G++A   + +W  +     +T    V G    + S   +RV  + VRD Q 
Sbjct  41   RLTAITLSIGVLAALLWAYWGKLDVQATATGRLVVSGRSQVIQSYEQSRVMSIHVRDGQR  100

Query  68   VDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKL---------------VQQGS  112
            V+KG  L+ L+       + R       +  EL + R+ L                +Q +
Sbjct  101  VEKGAPLLTLDTLGVNQDITRLITQSEFQTNELIRYRTLLNDQPLVQDPMFTALPTEQQA  160

Query  113  LI-----------------------------AASAADVNA--------SQATLGRAQIDL  135
            LI                             AA  +D+NA        SQ    R    L
Sbjct  161  LINENYLSEKREFDATLASISAEMKVNRTSQAARQSDINALIQLTENISQRLAARK--TL  218

Query  136  NRAEALRKPGYVSEER--------VTTLTADNHVARSQ---LAKARADLEAQRVQRDTLG  184
            N+ + +    Y+ +E+        V    A+  V +SQ   L + +   +AQ+  R+ L 
Sbjct  219  NQVKVIGHVEYLEQEKELLEVQRQVAQQRAELQVLKSQYQSLEERQTGFKAQK-HREWLE  277

Query  185  AEIKRLEA--QIASARTELAQAEINLSRTLIHSPISGLVGQRSARN-GQYVQVGTHLLSL  241
               KR +A  Q+A+   EL++        +I SP+ G V Q S    G  +Q   +L+ +
Sbjct  278  ---KRRQAKLQLAALNQELSKVREREQLEIIRSPVDGTVQQLSVYTLGAVLQPAQNLMII  334

Query  242  VPDEDIWV-QANFKETQVGRMRDGQKARLTFDAFPDT---PIDGRIDSLF--AASGAQFS  295
            VP+  + + +       VG +  GQ   +  DAFP T    ID  + S+   + +  Q  
Sbjct  335  VPENSVQLAEVQILNKDVGFVYPGQSVTVKVDAFPYTRYGTIDAELLSISRDSTTDEQLG  394

Query  296  LLPPDNATGNFTKVVQRIPVKIVFEADNPLHGRIRPGMSVEAEVELRDR  344
            L+ P     N   +V  I  + V          + PGMSV AE++   R
Sbjct  395  LVFPAQVQLNKNNIV--IDGQTV---------ELTPGMSVVAEIKTDKR  432


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++ ++E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEASLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I LNR+  +  P  G++ +
Sbjct  135  RYKPLVAADAISKQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDATVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 82/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDATVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 49.7 bits (117),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query  49   VASQLGARVEEVLVRDNQHVDKGQLLVRLEDADFKLAVERAQAALATREAELAQARSKLV  108
            V +Q+G  +++ L ++  +V  GQ L +++ + ++  +E A+A LAT +A LA+A + L 
Sbjct  75   VRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEANLESARAQLATAQATLAKADADLA  134

Query  109  QQGSLIAASA-----------------ADVNASQATLGRAQIDLNRAEALRKP--GYVSE  149
            +   L+AA A                 A V A+QA +  A I+LNR+  +  P  G++ +
Sbjct  135  RYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGINLNRSR-ITAPISGFIGQ  193

Query  150  ERVTTLTADNHVARSQLAKARADLEAQRVQRDTLGAEIKRLEAQIASAR  198
             +V+  T  N    + LA  R       V      +E+ +L  QIA  +
Sbjct  194  SKVSEGTLLNAGDTTVLATIR-QTNPMYVNVTQSASEVMKLRRQIAEGK  241



Lambda      K        H        a         alpha
   0.319    0.132    0.366    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2544744843


Query= g4677.t1

Length=425


***** No hits found *****



Lambda      K        H        a         alpha
   0.316    0.132    0.363    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 3354028314


Query= g5257.t1

Length=394
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  288     9e-95
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  283     1e-92
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  281     5e-92
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  281     1e-91
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  279     6e-91
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  278     8e-91
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  278     1e-90
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  278     2e-90
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  277     2e-90
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  277     2e-90
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  276     5e-90
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  275     2e-89
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  95.5    6e-22
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  59.7    1e-09
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  59.3    1e-09
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  59.3    1e-09
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  59.3    1e-09
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  59.3    1e-09
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  52.4    3e-07
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  51.6    4e-07
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  51.6    4e-07
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  50.8    6e-07
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  50.4    1e-06
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  50.4    1e-06
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  50.1    1e-06


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 288 bits (738),  Expect = 9e-95, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 206/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  VQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L  D  +   P+V+ A  +L+ A+L+  R+ + AP  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 283 bits (724),  Expect = 1e-92, Method: Compositional matrix adjust.
 Identities = 157/312 (50%), Positives = 208/312 (67%), Gaps = 1/312 (0%)

Query  38   FFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQ  97
            F + +  E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +
Sbjct  46   FLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYE  105

Query  98   RAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAH  157
            RA+  L   VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAH
Sbjct  106  RAKNELIQAVRQNRQQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAH  165

Query  158  ARDALDSAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAP  216
            AR A+  A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP
Sbjct  166  ARAAVSQAQAAVKAALAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAP  225

Query  217  VTGYVAKRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGS  276
              G VAKRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG 
Sbjct  226  TDGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGK  285

Query  277  DVRYSGTVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSM  336
             + Y G V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM
Sbjct  286  QIVYRGMVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSM  345

Query  337  DVKVDLHDQSGP  348
             VKVD    S P
Sbjct  346  TVKVDTSAASAP  357


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 281 bits (719),  Expect = 5e-92, Method: Compositional matrix adjust.
 Identities = 156/312 (50%), Positives = 207/312 (66%), Gaps = 1/312 (0%)

Query  38   FFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQ  97
            F + +  E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +
Sbjct  40   FLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYE  99

Query  98   RAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAH  157
            RA+  L   VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAH
Sbjct  100  RAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAH  159

Query  158  ARDALDSAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAP  216
            AR A+  A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP
Sbjct  160  ARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAP  219

Query  217  VTGYVAKRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGS  276
              G VAKRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG 
Sbjct  220  ADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGK  279

Query  277  DVRYSGTVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSM  336
             + Y G V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM
Sbjct  280  QIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSM  339

Query  337  DVKVDLHDQSGP  348
             VKVD      P
Sbjct  340  TVKVDTSAAGAP  351


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 281 bits (718),  Expect = 1e-91, Method: Compositional matrix adjust.
 Identities = 156/312 (50%), Positives = 207/312 (66%), Gaps = 1/312 (0%)

Query  38   FFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQ  97
            F + +  E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +
Sbjct  46   FLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYE  105

Query  98   RAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAH  157
            RA+  L   VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAH
Sbjct  106  RAKNELIQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAH  165

Query  158  ARDALDSAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAP  216
            AR A+  A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP
Sbjct  166  ARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAP  225

Query  217  VTGYVAKRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGS  276
              G VAKRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG 
Sbjct  226  ADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGK  285

Query  277  DVRYSGTVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSM  336
             + Y G V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM
Sbjct  286  QIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSM  345

Query  337  DVKVDLHDQSGP  348
             VKVD      P
Sbjct  346  TVKVDTSAAGAP  357


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 279 bits (713),  Expect = 6e-91, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 205/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  52   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  111

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  112  VQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  171

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P+V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  172  QAQAAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVA  231

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  232  KRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  291

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  292  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351

Query  343  HDQSGP  348
                 P
Sbjct  352  SAAGAP  357


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 278 bits (711),  Expect = 8e-91, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 204/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  VQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 278 bits (710),  Expect = 1e-90, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 204/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  IQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 278 bits (710),  Expect = 2e-90, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 204/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  VQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 277 bits (709),  Expect = 2e-90, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 204/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  IQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 277 bits (709),  Expect = 2e-90, Method: Compositional matrix adjust.
 Identities = 155/306 (51%), Positives = 204/306 (67%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  52   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  111

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  112  IQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  171

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I AP  G VA
Sbjct  172  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVA  231

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  232  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  291

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  292  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351

Query  343  HDQSGP  348
                 P
Sbjct  352  SAAGAP  357


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 276 bits (706),  Expect = 5e-90, Method: Compositional matrix adjust.
 Identities = 154/306 (50%), Positives = 203/306 (66%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  46   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  105

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  106  IQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  165

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I  P  G VA
Sbjct  166  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQVA  225

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  226  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  285

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  286  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  345

Query  343  HDQSGP  348
                 P
Sbjct  346  SAAGAP  351


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 275 bits (702),  Expect = 2e-89, Method: Compositional matrix adjust.
 Identities = 154/306 (50%), Positives = 203/306 (66%), Gaps = 1/306 (0%)

Query  44   HEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIALQRAEANL  103
             E+T+DAY+ G VVQ+TPQ  GTV  +  DD D V+KG  L   D  +  +A +RA+  L
Sbjct  52   EEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNEL  111

Query  104  AHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEELAHARDALD  163
               VRQ R   +      A+VA R+  LA+A+ D +RR  LA+ GA+S EELAHAR A+ 
Sbjct  112  VQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVS  171

Query  164  SAKASLTSSEQQLNTNRA-LVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVAPVTGYVA  222
             A+A++ ++  + ++ RA L     +   P V+ A  +L+ A+L+  R+ I A   G VA
Sbjct  172  QAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQVA  231

Query  223  KRSVQVGQRVQPGNALMAVVPLDQIWIDANFKETQLKHMRIGQPVEIRSDLYGSDVRYSG  282
            KRSVQVGQ+V  G  LMAVVPL  +W+DANFKETQL+HM+IGQP E+ SDLYG  + Y G
Sbjct  232  KRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRG  291

Query  283  TVDSLGVGTGSAFSLLPAQNATGNWIKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDL  342
             V     GTGSAFSL+PAQNATGNWIK+VQRVPVRI ++ +++ +HPLRIGLSM VKVD 
Sbjct  292  RVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDT  351

Query  343  HDQSGP  348
                 P
Sbjct  352  SAAGAP  357


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 95.5 bits (236),  Expect = 6e-22, Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 151/336 (45%), Gaps = 15/336 (4%)

Query  13   PKRKRWLLILLAMIVLATLASVAWEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGA  72
            PK    ++ILL + +   +   ++ F +      T++A++  NV  +   + G + +I  
Sbjct  5    PKAGFPVIILLCVFLFILIYHYSYLFPF------TNNAFVVANVRPVAANVKGYITNIYV  58

Query  73   DDGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALA  132
             +   V+KGQ L     +  ++A ++A +++     Q+      V+  +  +  +K    
Sbjct  59   KNEQEVKKGQPLFTVFKAPYELAYRKAVSHVQEAKAQLLLFNKQVEKTKYLLQAQKELYE  118

Query  133  KAEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHP  192
            K   DY+   + + D A+S+  +       ++A + L + E++L  N+  V    I    
Sbjct  119  KFRFDYEHNYSASRDHAVSKLTVNTMLKEKNAALSKLKALEKELEVNQQQV----IVQKK  174

Query  193  DVKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNALMAVVPLDQIWIDAN  252
             + +  A ++ A +D   +T+ A   G V    V +G  ++    + A+   D ++I AN
Sbjct  175  KIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVALGTPIKTRKPVFAIADTDTLFIQAN  234

Query  253  FKETQLKHMRIGQPVEIRSDLYGSDVRYSGTVDSLG-----VGTGSAFSLLPAQNATGNW  307
            F ET L+ ++ G  V I   +Y     Y G + S       + T  A  +   +N+  NW
Sbjct  235  FNETDLRRVQPGDKVSIFPRMYFGSKIYHGVILSRNWAASRLETHRATQIQIVRNSESNW  294

Query  308  IKIVQRVPVRIHIDPQELQKHPLRIGLSMDVKVDLH  343
              + QR+PV+I I   +   +PL IG S  V +  H
Sbjct  295  FLLPQRLPVQIQITDYDPVHYPLSIGASAYVYIHTH  330


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 59.7 bits (143),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query  36   WEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIA  95
            W+ + GR  E  D        V I PQ+ G +V++   DG LV+KG  L   DP   +  
Sbjct  59   WQEYSGRL-EAIDQ-------VDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  96   LQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEEL  155
            L RA+A LA    QV    SN+                      R + L    A+S++EL
Sbjct  111  LNRAKAQLASAEAQVTYTASNL---------------------SRIQRLIQSNAVSRQEL  149

Query  156  AHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVA  215
              A +   SA A+L                         +AA A ++ A L+   + I A
Sbjct  150  DLAENDARSANANL-------------------------QAARAAVQSARLNLEYTRITA  184

Query  216  PVTGYVAKRSVQVGQRVQPGNA---LMAVVPLDQIWIDANFKE-TQLKHM  261
            PV+G +++  V VG  V  GN    L ++V + +++   +  E T LK++
Sbjct  185  PVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 59.3 bits (142),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 62/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query  36   WEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIA  95
            W+ + GR  E  D        V I PQ+ G ++++   DG LV+KG  L   DP   +  
Sbjct  35   WQEYSGRL-EAIDQ-------VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  86

Query  96   LQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEEL  155
            L RA+A LA    QV    SN+                      R + L    A+S++EL
Sbjct  87   LNRAKAQLASAEAQVTYTASNL---------------------SRIQRLIQSNAVSRQEL  125

Query  156  AHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVA  215
              A +   SA A+L                         +AA A ++ A L+   + I A
Sbjct  126  DLAENDARSANANL-------------------------QAARAAVQSARLNLEYTRITA  160

Query  216  PVTGYVAKRSVQVGQRVQPGNA---LMAVVPLDQIWIDANFKE-TQLKHM  261
            PV+G +++  V VG  V  GN    L ++V + +++   +  E T LK++
Sbjct  161  PVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  210


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 59.3 bits (142),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 62/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query  36   WEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIA  95
            W+ + GR  E  D        V I PQ+ G ++++   DG LV+KG  L   DP   +  
Sbjct  59   WQEYSGRL-EAIDQ-------VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  96   LQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEEL  155
            L RA+A LA    QV    SN+                      R + L    A+S++EL
Sbjct  111  LNRAKAQLASAEAQVTYTASNL---------------------SRIQRLIQSNAVSRQEL  149

Query  156  AHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVA  215
              A +   SA A+L                         +AA A ++ A L+   + I A
Sbjct  150  DLAENDARSANANL-------------------------QAARAAVQSARLNLEYTRITA  184

Query  216  PVTGYVAKRSVQVGQRVQPGNA---LMAVVPLDQIWIDANFKE-TQLKHM  261
            PV+G +++  V VG  V  GN    L ++V + +++   +  E T LK++
Sbjct  185  PVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 59.3 bits (142),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 62/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query  36   WEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIA  95
            W+ + GR  E  D        V I PQ+ G ++++   DG LV+KG  L   DP   +  
Sbjct  59   WQEYSGRL-EAIDQ-------VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  96   LQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEEL  155
            L RA+A LA    QV    SN+                      R + L    A+S++EL
Sbjct  111  LNRAKAQLASAEAQVTYTASNL---------------------SRIQRLIQSNAVSRQEL  149

Query  156  AHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVA  215
              A +   SA A+L                         +AA A ++ A L+   + I A
Sbjct  150  DLAENDARSANANL-------------------------QAARAAVQSARLNLEYTRITA  184

Query  216  PVTGYVAKRSVQVGQRVQPGNA---LMAVVPLDQIWIDANFKE-TQLKHM  261
            PV+G +++  V VG  V  GN    L ++V + +++   +  E T LK++
Sbjct  185  PVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 59.3 bits (142),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 62/230 (27%), Positives = 97/230 (42%), Gaps = 58/230 (25%)

Query  36   WEFFYGRWHEDTDDAYINGNVVQITPQIVGTVVSIGADDGDLVRKGQELVRFDPSDADIA  95
            W+ + GR  E  D        V I PQ+ G ++++   DG LV+KG  L   DP   +  
Sbjct  59   WQEYSGRL-EAIDQ-------VDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAE  110

Query  96   LQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAKAEADYKRRKNLADDGAISQEEL  155
            L RA+A LA    QV    SN+                      R + L    A+S++EL
Sbjct  111  LNRAKAQLASAEAQVTYTASNL---------------------SRIQRLIQSNAVSRQEL  149

Query  156  AHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPDVKAAAAQLRQAYLDDARSTIVA  215
              A +   SA A+L                         +AA A ++ A L+   + I A
Sbjct  150  DLAENDARSANANL-------------------------QAARAAVQSARLNLEYTRITA  184

Query  216  PVTGYVAKRSVQVGQRVQPGNA---LMAVVPLDQIWIDANFKE-TQLKHM  261
            PV+G +++  V VG  V  GN    L ++V + +++   +  E T LK++
Sbjct  185  PVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYI  234


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 52.4 bits (124),  Expect = 3e-07, Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  + +L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEASLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    AIS++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAADAISKQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A +   RS I AP++G++ +  V  G  +  G+A  L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 51.6 bits (122),  Expect = 4e-07, Method: Compositional matrix adjust.
 Identities = 49/191 (26%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    AIS++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVSADAISKQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 51.6 bits (122),  Expect = 4e-07, Method: Compositional matrix adjust.
 Identities = 49/191 (26%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    AIS++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVSADAISKQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 50.8 bits (120),  Expect = 6e-07, Method: Compositional matrix adjust.
 Identities = 49/191 (26%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A +   RS I AP++G++ +  V  G  +  G+A  L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 50.4 bits (119),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 50.4 bits (119),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +  L+ A                     RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYEAGLESA---------------------RAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 50.1 bits (118),  Expect = 1e-06, Method: Compositional matrix adjust.
 Identities = 47/191 (25%), Positives = 82/191 (43%), Gaps = 48/191 (25%)

Query  74   DGDLVRKGQELVRFDPSDADIALQRAEANLAHTVRQVRGLFSNVDGYRAEVATRKVALAK  133
            +G  VR GQ L + D S  +                     +N++  RA++AT +  LAK
Sbjct  90   EGSYVRAGQPLYQIDSSTYE---------------------ANLESARAQLATAQATLAK  128

Query  134  AEADYKRRKNLADDGAISQEELAHARDALDSAKASLTSSEQQLNTNRALVDDTQITSHPD  193
            A+AD  R K L    A+S++E   A  A  SA+A                          
Sbjct  129  ADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAG-------------------------  163

Query  194  VKAAAAQLRQAYLDDARSTIVAPVTGYVAKRSVQVGQRVQPGNA--LMAVVPLDQIWIDA  251
            VKAA A ++ A ++  RS I AP++G++ +  V  G  +  G+   L  +   + ++++ 
Sbjct  164  VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTTVLATIRQTNPMYVNV  223

Query  252  NFKETQLKHMR  262
                +++  +R
Sbjct  224  TQSASEVMKLR  234



Lambda      K        H        a         alpha
   0.316    0.131    0.371    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 3049711948


Query= g2613.t1

Length=390
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  291     9e-96
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  290     2e-95
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  288     1e-94
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  288     1e-94
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  285     3e-93
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  284     5e-93
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  283     6e-93
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  283     6e-93
VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protei...  283     7e-93
VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protei...  283     7e-93
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  283     1e-92
VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protei...  281     7e-92
VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretio...  92.4    8e-21
VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  53.1    1e-07
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  52.8    2e-07
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  52.8    2e-07
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  52.8    2e-07
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  52.8    2e-07


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 291 bits (744),  Expect = 9e-96, Method: Compositional matrix adjust.
 Identities = 180/385 (47%), Positives = 250/385 (65%), Gaps = 5/385 (1%)

Query  6    EIQTPQQPAKKKGKRKTALLLLTLLFVIIAVAYGIYWFLVLRHIEETDDAYVAGNQVQIM  65
            +IQ  Q+    K KRK  L  LTLLF + AVA G  +FL  +H EET+DAYVAG  VQ+ 
Sbjct  9    KIQNGQEADSAKAKRKRRLTALTLLFALAAVAAGSAFFLWWQHEEETEDAYVAGRVVQVT  68

Query  66   AQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLMINSKQL  125
             Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  L  +VRQ  +    + Q 
Sbjct  69   PQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNAATSQA  128

Query  126  QANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAI-QQYNAN  184
             A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV+ AQA +  A+ ++ +A 
Sbjct  129  AAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSAR  188

Query  185  QAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLM  244
             A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V++R+VQ G Q++   PLM
Sbjct  189  AALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLM  248

Query  245  AVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYTGKVVGLDMGTGSAFSLLP  304
            AVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y G+V G   GTGSAFSL+P
Sbjct  249  AVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIP  308

Query  305  AQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVDTANRDGQVLASQVRTTPV  364
            AQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VDT+     V  +     P 
Sbjct  309  AQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPE  368

Query  365  AESNAREINLAPVNKLIDDIVQANA  389
             ES     + + V++ +D+I+  +A
Sbjct  369  IEST----DWSEVDRTVDEILGQSA  389


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 290 bits (742),  Expect = 2e-95, Method: Compositional matrix adjust.
 Identities = 156/343 (45%), Positives = 221/343 (64%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  45   HEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  104

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  105  LVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAV  164

Query  168  A-SAQAQLDVAIQQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + +  A      ++ +A  A+  + +L +QP VQ A   +++AWL L RT++ +P  G V
Sbjct  165  SQAQAAVKAALAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQV  224

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  285  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  344

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 288 bits (738),  Expect = 1e-94, Method: Compositional matrix adjust.
 Identities = 181/384 (47%), Positives = 247/384 (64%), Gaps = 5/384 (1%)

Query  7    IQTPQQPAKKKGKRKTALLLLTLLFVIIAVAYGIYWFLVLRHIEETDDAYVAGNQVQIMA  66
            IQ  Q+    K KRK  L  LTLLF + AVA G  +FL  +H EET+DAYVAG  VQ+  
Sbjct  10   IQNRQEANSAKVKRKRRLTALTLLFALAAVAAGSAFFLWWQHEEETEDAYVAGRVVQVTP  69

Query  67   QVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLMINSKQLQ  126
            Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  L  +VRQ  Q    + Q  
Sbjct  70   QKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRQQNAATSQAG  129

Query  127  ANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAI-QQYNANQ  185
            A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV+ AQA +  A+ ++ +A  
Sbjct  130  AQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARA  189

Query  186  AMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLMA  245
            A+     L +QPAVQ A   +++AWL L+RT+I +P  G V++R+VQ G Q++   PLMA
Sbjct  190  ALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRSVQVGQQVAAGAPLMA  249

Query  246  VVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYTGKVVGLDMGTGSAFSLLPA  305
            VVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y G V G   GTGSAFSL+PA
Sbjct  250  VVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGMVAGFSAGTGSAFSLIPA  309

Query  306  QNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVDTANRDGQVLASQVRTTPVA  365
            QNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VDT+     V  +     P  
Sbjct  310  QNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAASAPVSKTPGAALPEM  369

Query  366  ESNAREINLAPVNKLIDDIVQANA  389
            ES     + + V++ +D+I+  +A
Sbjct  370  EST----DWSEVDRTVDEILGQSA  389


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 288 bits (736),  Expect = 1e-94, Method: Compositional matrix adjust.
 Identities = 163/349 (47%), Positives = 230/349 (66%), Gaps = 5/349 (1%)

Query  42   WFLVLRHIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAF  101
            +FL  +H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+
Sbjct  39   FFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  102  EKAKTALASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQ  161
            E+AK  L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL 
Sbjct  99   ERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELA  158

Query  162  HARDAVASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVS  220
            HAR AV+ AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +
Sbjct  159  HARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRA  218

Query  221  PMTGYVSRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYG  280
            P  G V++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG
Sbjct  219  PADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYG  278

Query  281  DDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLS  340
              + Y G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS
Sbjct  279  KQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS  338

Query  341  TLVTVDTANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
              V VDT+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  339  MTVKVDTSAAGAPVSKTPGAALPEIEST----DWSEVDRTVDEILGQSA  383


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 285 bits (728),  Expect = 3e-93, Method: Compositional matrix adjust.
 Identities = 179/385 (46%), Positives = 249/385 (65%), Gaps = 5/385 (1%)

Query  6    EIQTPQQPAKKKGKRKTALLLLTLLFVIIAVAYGIYWFLVLRHIEETDDAYVAGNQVQIM  65
            +IQ  Q+    K KRK  L  LTLLF + A A G  +FL  +H EET+DAYVAG  VQ+ 
Sbjct  9    KIQNRQEADSAKAKRKRCLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVT  68

Query  66   AQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLMINSKQL  125
             Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  L  +VRQ  +    + Q 
Sbjct  69   PQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRRQNAATSQA  128

Query  126  QANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAI-QQYNAN  184
             A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV+ AQA +  A+ ++ +A 
Sbjct  129  GAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSAR  188

Query  185  QAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQISPTTPLM  244
             A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V++R+VQ G Q++   PLM
Sbjct  189  AALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLM  248

Query  245  AVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYTGKVVGLDMGTGSAFSLLP  304
            AVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y G+V G   GTGSAFSL+P
Sbjct  249  AVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIP  308

Query  305  AQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVDTANRDGQVLASQVRTTPV  364
            AQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VDT+     V  +     P 
Sbjct  309  AQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPE  368

Query  365  AESNAREINLAPVNKLIDDIVQANA  389
             ES     + + V++ +D+I+  +A
Sbjct  369  MEST----DWSEVDRTVDEILGQSA  389


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 284 bits (726),  Expect = 5e-93, Method: Compositional matrix adjust.
 Identities = 161/343 (47%), Positives = 226/343 (66%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  45   HEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  104

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  105  LVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAV  164

Query  168  ASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V
Sbjct  165  SQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQV  224

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  285  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  344

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 283 bits (725),  Expect = 6e-93, Method: Compositional matrix adjust.
 Identities = 162/349 (46%), Positives = 229/349 (66%), Gaps = 8/349 (2%)

Query  42   WFLVLRHIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAF  101
            W+   +H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+
Sbjct  42   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  98

Query  102  EKAKTALASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQ  161
            E+AK  L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL 
Sbjct  99   ERAKNELIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELA  158

Query  162  HARDAVASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVS  220
            HAR AV+ AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +
Sbjct  159  HARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRA  218

Query  221  PMTGYVSRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYG  280
            P  G V++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG
Sbjct  219  PADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYG  278

Query  281  DDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLS  340
              + Y G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS
Sbjct  279  KQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS  338

Query  341  TLVTVDTANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
              V VDT+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  339  MTVKVDTSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 283 bits (725),  Expect = 6e-93, Method: Compositional matrix adjust.
 Identities = 161/343 (47%), Positives = 226/343 (66%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  45   HEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  104

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  105  LIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAV  164

Query  168  ASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V
Sbjct  165  SQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQV  224

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  285  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  344

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036946(gb|WP_041266574) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha710]
Length=384

 Score = 283 bits (725),  Expect = 7e-93, Method: Compositional matrix adjust.
 Identities = 161/343 (47%), Positives = 226/343 (66%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  45   HEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  104

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  105  LIQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAV  164

Query  168  ASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V
Sbjct  165  SQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRTPADGQV  224

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  285  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  344

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036943(gb|WP_002245854) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis WUE 2594]
Length=384

 Score = 283 bits (725),  Expect = 7e-93, Method: Compositional matrix adjust.
 Identities = 161/343 (47%), Positives = 226/343 (66%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  45   HEEETEDAYVAGRVVQVTPQKGGTVWKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  104

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  105  LVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAV  164

Query  168  ASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +P  G V
Sbjct  165  SQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQV  224

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  225  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  284

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  285  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  344

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  383


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 283 bits (724),  Expect = 1e-92, Method: Compositional matrix adjust.
 Identities = 161/349 (46%), Positives = 228/349 (65%), Gaps = 8/349 (2%)

Query  42   WFLVLRHIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAF  101
            W+   +H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+
Sbjct  48   WW---QHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAY  104

Query  102  EKAKTALASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQ  161
            E+AK  L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL 
Sbjct  105  ERAKNELVQAVRQNRRQNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELA  164

Query  162  HARDAVASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVS  220
            HAR AV+ AQA +  A+ ++ +A  A+    +L +QP VQ A   +++AWL L+RT+I +
Sbjct  165  HARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRA  224

Query  221  PMTGYVSRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYG  280
            P  G V++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG
Sbjct  225  PADGQVAKRSVQVGQQVAAGAPLMAVVPLSDMWVDANFKETQLRHMKIGQPAELVSDLYG  284

Query  281  DDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLS  340
              + Y G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS
Sbjct  285  KQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLS  344

Query  341  TLVTVDTANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
              V VDT+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  345  MTVKVDTSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  389


>VFG036947(gb|WP_041423527) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis G2136]
Length=390

 Score = 281 bits (719),  Expect = 7e-92, Method: Compositional matrix adjust.
 Identities = 160/343 (47%), Positives = 225/343 (66%), Gaps = 5/343 (1%)

Query  48   HIEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTA  107
            H EET+DAYVAG  VQ+  Q  G+V KV  D+TD VK+GDVL  LD  +   A+E+AK  
Sbjct  51   HEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNE  110

Query  108  LASSVRQTHQLMINSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAV  167
            L  +VRQ  +    + Q  A + +++  LA+AQ DL RR  L  +  +  EEL HAR AV
Sbjct  111  LVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAV  170

Query  168  ASAQAQLDVAI-QQYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYV  226
            + AQA +  A+ ++ +A  A+    +L +QPAVQ A   +++AWL L+RT+I +   G V
Sbjct  171  SQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRASADGQV  230

Query  227  SRRAVQPGAQISPTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYT  286
            ++R+VQ G Q++   PLMAVVP +D+WVDANFKETQL +M+IGQP  +++D+YG  + Y 
Sbjct  231  AKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYR  290

Query  287  GKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVD  346
            G+V G   GTGSAFSL+PAQNATGNWIKVVQR+PVR+ L+   +++HPLRIGLS  V VD
Sbjct  291  GRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVD  350

Query  347  TANRDGQVLASQVRTTPVAESNAREINLAPVNKLIDDIVQANA  389
            T+     V  +     P  ES     + + V++ +D+I+  +A
Sbjct  351  TSAAGAPVSKTPGAALPEMEST----DWSEVDRTVDEILGQSA  389


>VFG045489(gb|WP_010946018) (LPG_RS01290) Dot/Icm type IV secretion 
system effector [Dot/Icm T4SS secreted effectors (VF0798) 
- Effector delivery system (VFC0086)] [Legionella pneumophila 
subsp. pneumophila str. Philadelphia 1]
Length=330

 Score = 92.4 bits (228),  Expect = 8e-21, Method: Compositional matrix adjust.
 Identities = 92/354 (26%), Positives = 160/354 (45%), Gaps = 49/354 (14%)

Query  15   KKKGKRKTALLLLTLLFVIIAVAYGIYWFLVLRHIEETDDAYVAGNQVQIMAQVSGSVTK  74
            K K      +LL   LF++I     ++ F        T++A+V  N   + A V G +T 
Sbjct  4    KPKAGFPVIILLCVFLFILIYHYSYLFPF--------TNNAFVVANVRPVAANVKGYITN  55

Query  75   VWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTH-QLMINSKQLQANIDVQK  133
            ++  N   VK+G  L T+ +   + A+ KA     S V++   QL++ +KQ      V+K
Sbjct  56   IYVKNEQEVKKGQPLFTVFKAPYELAYRKA----VSHVQEAKAQLLLFNKQ------VEK  105

Query  134  TA-LAQAQSDLNRRVPLGNANLIGREELQH----ARDAVASAQAQLDVAIQQYNA--NQA  186
            T  L QAQ +L  +          R + +H    +RD  A ++  ++  +++ NA  ++ 
Sbjct  106  TKYLLQAQKELYEKF---------RFDYEHNYSASRDH-AVSKLTVNTMLKEKNAALSKL  155

Query  187  MILNSNLE---DQPAVQQAATE-----VRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
              L   LE    Q  VQ+   +     ++NA + L+ T + +   G V    V  G  I 
Sbjct  156  KALEKELEVNQQQVIVQKKKIDSLIAVMKNAKIDLDETTVYAKQNGAVQDMFVALGTPIK  215

Query  239  PTTPLMAVVPATDLWVDANFKETQLANMRIGQPVTVITDIYGDDVKYTGKVVGLD-----  293
               P+ A+     L++ ANF ET L  ++ G  V++   +Y     Y G ++  +     
Sbjct  216  TRKPVFAIADTDTLFIQANFNETDLRRVQPGDKVSIFPRMYFGSKIYHGVILSRNWAASR  275

Query  294  MGTGSAFSLLPAQNATGNWIKVVQRLPVRVELDARQLEQHPLRIGLSTLVTVDT  347
            + T  A  +   +N+  NW  + QRLPV++++       +PL IG S  V + T
Sbjct  276  LETHRATQIQIVRNSESNWFLLPQRLPVQIQITDYDPVHYPLSIGASAYVYIHT  329


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 53.1 bits (126),  Expect = 1e-07, Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 46/179 (26%)

Query  60   NQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLM  119
            +QV I  QVSG +  V   +   VK+GD+L T+D    +    +AK  LAS+  Q     
Sbjct  70   DQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQ-----  124

Query  120  INSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQ  179
                       V  TA     S+L+R   L  +N + R+EL  A +   SA A L     
Sbjct  125  -----------VTYTA-----SNLSRIQRLIQSNAVSRQELDLAENDARSANANL-----  163

Query  180  QYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
                                Q A   V++A L LE TRI +P++G +SR  V  G  +S
Sbjct  164  --------------------QAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVS  202


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 52.8 bits (125),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 46/179 (26%)

Query  60   NQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLM  119
            +QV I  QVSG +  V   +   VK+GD+L T+D    +    +AK  LAS+  Q     
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQ-----  124

Query  120  INSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQ  179
                       V  TA     S+L+R   L  +N + R+EL  A +   SA A L     
Sbjct  125  -----------VTYTA-----SNLSRIQRLIQSNAVSRQELDLAENDARSANANL-----  163

Query  180  QYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
                                Q A   V++A L LE TRI +P++G +SR  V  G  +S
Sbjct  164  --------------------QAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVS  202


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 52.8 bits (125),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 46/179 (26%)

Query  60   NQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLM  119
            +QV I  QVSG +  V   +   VK+GD+L T+D    +    +AK  LAS+  Q     
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQ-----  124

Query  120  INSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQ  179
                       V  TA     S+L+R   L  +N + R+EL  A +   SA A L     
Sbjct  125  -----------VTYTA-----SNLSRIQRLIQSNAVSRQELDLAENDARSANANL-----  163

Query  180  QYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
                                Q A   V++A L LE TRI +P++G +SR  V  G  +S
Sbjct  164  --------------------QAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVS  202


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 52.8 bits (125),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 46/179 (26%)

Query  60   NQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLM  119
            +QV I  QVSG +  V   +   VK+GD+L T+D    +    +AK  LAS+  Q     
Sbjct  70   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQ-----  124

Query  120  INSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQ  179
                       V  TA     S+L+R   L  +N + R+EL  A +   SA A L     
Sbjct  125  -----------VTYTA-----SNLSRIQRLIQSNAVSRQELDLAENDARSANANL-----  163

Query  180  QYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
                                Q A   V++A L LE TRI +P++G +SR  V  G  +S
Sbjct  164  --------------------QAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVS  202


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 52.8 bits (125),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 76/179 (42%), Gaps = 46/179 (26%)

Query  60   NQVQIMAQVSGSVTKVWADNTDFVKEGDVLVTLDQTDAKQAFEKAKTALASSVRQTHQLM  119
            +QV I  QVSG +  V   +   VK+GD+L T+D    +    +AK  LAS+  Q     
Sbjct  46   DQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQ-----  100

Query  120  INSKQLQANIDVQKTALAQAQSDLNRRVPLGNANLIGREELQHARDAVASAQAQLDVAIQ  179
                       V  TA     S+L+R   L  +N + R+EL  A +   SA A L     
Sbjct  101  -----------VTYTA-----SNLSRIQRLIQSNAVSRQELDLAENDARSANANL-----  139

Query  180  QYNANQAMILNSNLEDQPAVQQAATEVRNAWLALERTRIVSPMTGYVSRRAVQPGAQIS  238
                                Q A   V++A L LE TRI +P++G +SR  V  G  +S
Sbjct  140  --------------------QAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVS  178



Lambda      K        H        a         alpha
   0.316    0.129    0.356    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 3007935072


  Database: VFDB_setB_pro.fas
    Posted date:  Apr 10, 2024  11:56 PM
  Number of letters in database: 13,298,383
  Number of sequences in database:  27,982



Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Neighboring words threshold: 11
Window for multiple hits: 40
